Overview
Carrie-Anne Ridsdale (Carrie), who presents publicly as Jayne Price has consistently claimed to suffer from aplastic anemia, describing severe symptoms including low hemoglobin and the need for transfusions, but these claims remain unsupported by external medical verification.
Carrie first publicly disclosed having a massive tumour and aplastic anemia in late 2022, describing the condition as a rare blood and bone marrow cancer and stating they were receiving treatment. Early claims included symptoms such as inability to work due to shielding and the need for vitamin B12 and vitamin C injections to aid iron absorption. By early 2024, Carrie reported a significant drop in iron levels requiring further tests, and by mid-2024, they detailed having iron deficiency anemia preceding the onset of aplastic anemia, attributing the latter to tumour effects. Hemoglobin levels were reported as critically low, with values around 63, well below the normal range for women, and Carrie described long-term palliative care with no expectation of cure.
Throughout 2025, Carrie-Anne Ridsdale expanded on their medical narrative, reporting multiple types of anemia including folate deficient anemia, and describing symptoms such as fatigue, pallor, and cognitive effects attributed to aplastic anemia. They mentioned investigatory procedures on the bowel and gastric systems due to low hemoglobin and fluctuating iron tablet adherence, which they linked to fatigue. Carrie also described pain in the lower spine as related to aplastic anemia and expressed frustration with their condition and treatment regimen. They reported receiving blood transfusions and iron infusions, noting improvements but also ongoing needs for further treatment. Carrie stated they were under oncology and haematology care and mentioned a bone marrow transplant as a possible future intervention.
Carrie's medical descriptions included some inaccuracies or misunderstandings, such as describing aplastic anemia as a cancer and implying that hemoglobin drops cause a complete lack of oxygen in the blood. They also linked pica disorder symptoms, such as craving ice, to their anemia. Despite detailed personal accounts, there is no external medical documentation or verification of these conditions in the evidence. Carrie-Anne Ridsdale's claims about their tumor being found on an MRI in 2015 but not acted upon by a GP add a historical dimension to their illness narrative.
In the most recent statements from early 2026, Carrie reiterated their diagnosis of aplastic anemia and the impact on red blood cell production. They continue to report ongoing treatment with transfusions and iron infusions, with some improvement noted. Carrie also disclosed behaviours related to medication management, including periods off iron tablets and restarting them to manage fatigue.
Overall, Carrie's narrative about aplastic anemia and related anemia conditions is consistent internally but lacks external corroboration. The claims include medically plausible symptoms and treatments but also some inaccuracies in medical understanding. Carrie-Anne Ridsdale's detailed personal health disclosures appear sincere but remain unsupported by independent medical records or official confirmation. This limits the ability to fully verify the severity or exact nature of Carrie's condition. The case significance lies primarily in Carrie's public health claims and their impact on personal and operational credibility rather than clinical risk or regulatory breach.